www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Lawyer, Attorney, Counsel, Law Firm, & then ANUSHAVAN G. TOROSYAN v. ...
action alleging that the defendant, Boehringer Ingelheim Pharmaceuticals, Inc...
Nov 22, 2010 ... NAIK v. BOEHRINGER INGELHEIM PHARMACEUTICALS INCORPORATED ...
fired by his employer, Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), ... 29
U.S.C. §§ 621 et seq., and Title VII of the Civil Rights Act of 1964, ...
The latest litigation news involving the company Boehringer Ingelheim () ...
principal scientist at Boehringer-Ingelheim Pharmaceuticals Inc. The opinions
expressed are those of the author(s. ...  Boehringer Ingelheim Vetmedica, Inc.
Jun 8, 2009 ... exenatide (1.93 vs 2.60 events per patient .... Pharmaceuticals Inc, San Diego,
CA, USA), and ..... Henriksen, K Hermansen, S Hippler, J ... fonsultant for
Boehringer- Ingelheim ... Nathan DM, Buse JB, Davidson MB, et al.
Aug 16, 2016 ... mathematical modelling to predict real-world effectiveness of drug interventions
is ... used to make predictions (Spiegelhalter et al., 2003) or to inform ..... statins (
rosuvastatin 20 mg vs. atorvastatin 40 mg and rosuvastatin 40 mg .... Gsteiger
received a direct financial contribution from Boehringer. Ingelheim.
Published by Baishideng Publishing Group Inc. All rights reserved. .... An
analysis by Birkmeyer et al showed absolute differences in 5-year survival .... in
overall survival compared to patients who had not had surgery (14.4 mo vs 7.2
mo), ..... Bristol Myers Squipp, Boehringer Ingelheim, Daiichi-Sankyo, Leo
Pharma, Novartis ...
employees currently working for a corporation, all trees in a forest), sample ..... F.
King, Statistics in Antitrust Litigation, in Statistics and the Law 49 (Morris H.
DeGroot et al. eds., .... E.g., Boehringer Ingelheim G.m.b.H. v. ...... Norbert
Schwarz & Hans-Jürgen Hippler, Response Alternatives: The Impact of Their
EFFECT OF PRASUGREL VS CLOPIDOGREL ON HOSPITAL READMISSION .....
QC, Canada, <sup>2</sup>Institut national d'excellence en santé et services sociaux,
Montreal, QC, .... <sup>1</sup>University of Utah, Salt Lake City, UT, USA, <sup>2</sup>Boehringer
Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA ..... Asche C<sup>1</sup>, Ren J<sup>1</sup>,
Mar 15, 2016 ... An analysis by Birkmeyer et al showed absolute differences in 5-year survival
.... Median DFS (Gem 14.3 mo vs 14.1 mo; P = 0.53) and OS (Gem 23.2 mo vs 5-
FU .... Bristol Myers Squipp, Boehringer Ingelheim, Daiichi-Sankyo, Leo Pharma,
.... Kamphues C, Bova R, Schricke D, Hippler-Benscheidt M, ...